SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-24-002391
Filing Date
2024-08-02
Accepted
2024-08-02 16:30:44
Documents
1
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 zk2431765.html 4  
1 zk2431765.xml 4 6393
  Complete submission text file 0001178913-24-002391.txt   7901
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON MA 02135
Business Address
Toledano Miranda Jayne (Reporting) CIK: 0001686530 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38556 | Film No.: 241171511